Sodium 3-methyl-2-oxobutanoate-13C4,d3

CAT:
804-HY-W006057AS13
Size:
1 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Sodium 3-methyl-2-oxobutanoate-13C4,d3 - image 1

Sodium 3-methyl-2-oxobutanoate-13C4,d3

  • UNSPSC Description:

    Sodium 3-methyl-2-oxobutanoate-13C4,d3 is the deuterium and 13C labeled Sodium 3-methyl-2-oxobutanoate[1]. Sodium 3-methyl-2-oxobutanoate is a precursor of pantothenic acid in Escherichia coli[2][3][4].
  • Target Antigen:

    Endogenous Metabolite
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Metabolic Enzyme/Protease
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Others
  • Solubility:

    10 mM in DMSO
  • Smiles:

    [13CH3][13CH](C([2H])([2H])[2H])[13C]([13C](O[Na])=O)=O
  • Molecular Weight:

    145.09
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]MAAS WK, et al. alpha-Ketoisovaleric acid, a precursor of pantothenic acid in Escherichia coli. J Bacteriol. 1953 Apr;65(4):388-93.|[3]Schauder P, et al. Oral administration of alpha-ketoisovaleric acid or valine in humans: blood kinetics and biochemical effects. J Lab Clin Med. 1984 Apr103(4):597-605.|[4]Coitinho AS, et al. Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res. 2001 Mar 9894(1):68-73.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported
  • CAS Number:

    1215605-14-3